The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
High-Density Lipoprotein Function, Dysfunction, and Reverse Cholesterol Transport
Open accessAbstract
Although high high-density lipoprotein (HDL)-cholesterol levels are associated with decreased cardiovascular risk in epidemiological studies, recent genetic and pharmacological findings have raised doubts about the beneficial effects of HDL. Raising HDL levels in animal models by infusion or overexpression of apolipoprotein A-I has shown clear vascular improvements, such as delayed atherosclerotic lesion progression and accelerated lesion regression, along with increased reverse cholesterol transport. Inflammation and other factors, such as myeloperoxidase-mediated oxidation, can impair HDL production and HDL function, with regard to its reverse cholesterol transport, antioxidant, and anti-inflammatory activities. Thus, tests of HDL function, which have not yet been developed as routine diagnostic assays, may prove useful and be a better predictor of cardiovascular risk than HDL-cholesterol levels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
High density lipoprotein as a protective factor against coronary heart disease
Gordon, T., Castelli, W. P., Hjortland, M. C., Kannel, W. B., & Dawber, T. R. (1977) · The American Journal of Medicine · doi:10.1016/0002-9343(77)90874-9 · Cited by 5,059
Effects of torcetrapib in patients at high risk for coronary events
Barter, P. J., Caulfield, M., Eriksson, M., Grundy, S. M., Kastelein, J. J. P., Komajda, M., Lopez-Sendon, J., Mosca, L., Tardif, J.-C., Waters, D. D., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706628 · Cited by 3,139
Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
The AIM-HIGH Investigators (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107579 · Cited by 2,911
The plasma lecithin:cholesterol acyltransferase reaction
Glomset, J. A. (1968) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43114-1 · Cited by 2,405
Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis
Khera, A. V., Cuchel, M., de la Llera-Moya, M., Rodrigues, A., Burke, M. F., Jafri, K., French, B. C., Phillips, J. A., Mucksavage, M. L., Wilensky, R. L., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1001689 · Cited by 1,943
Nissen, S. E., Tsunoda, T., Tuzcu, E. M., Schoenhagen, P., Cooper, C. J., Yasin, M., Eaton, G. M., Lauer, M. A., Sheldon, W. S., Grines, C. L., et al. (2003) · JAMA · doi:10.1001/jama.290.17.2292 · Cited by 1,707
Incidence of Coronary Heart Disease and Lipoprotein Cholesterol Levels: The Framingham Study
Castelli, W. P. (1986) · JAMA · doi:10.1001/jama.1986.03380200073024 · Cited by 1,611
The Framingham Study: The Epidemiology of Atherosclerotic Disease
Dawber, T. R. (1980) · Harvard University Press eBooks · doi:10.4159/harvard.9780674492097 · Cited by 1,454
Bouhlel, M. A., Derudas, B., Rigamonti, E., Dièvart, R., Brozek, J., Haulon, S., Zawadzki, C., Jude, B., Torpier, G., Marx, N., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.06.010 · Cited by 1,325
MiR-33 Contributes to the Regulation of Cholesterol Homeostasis
Rayner, K. J., Suárez, Y., Dávalos, A., Parathath, S., Fitzgerald, M. L., Tamehiro, N., Fisher, E. A., Moore, K. J., & Fernández-Hernando, C. (2010) · Science · doi:10.1126/science.1189862 · Cited by 1,260
Self-citationPrognostic Value of Myeloperoxidase in Patients with Chest Pain
Brennan, M.-L., Penn, M. S., Van Lente, F., Nambi, V., Shishehbor, M. H., Aviles, R. J., Goormastic, M., Pepoy, M. L., McErlean, E. S., Topol, E. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035003 · Cited by 1,070
Self-citationWang, N., Lan, D., Chen, W., Matsuura, F., & Tall, A. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403506101 · Cited by 1,061
Association Between Myeloperoxidase Levels and Risk of Coronary Artery Disease
Zhang, R. (2001) · JAMA · doi:10.1001/jama.286.17.2136 · Cited by 918
Van Lenten, B. J., Hama, S. Y., de Beer, F. C., Stafforini, D. M., McIntyre, T. M., Prescott, S. M., La Du, B. N., Fogelman, A. M., & Navab, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118345 · Cited by 840
Badimon, J. J., Badimon, L., & Fuster, V (1990) · Journal of Clinical Investigation · doi:10.1172/jci114558 · Cited by 764
Navab, M., Imes, S. S., Hama, S. Y., Hough, G. P., Ross, L. A., Bork, R. W., Valente, A. J., Berliner, J. A., Drinkwater, D. C., & Laks, H. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115532 · Cited by 737
Zheng, L., Nukuna, B., Brennan, M.-L., Sun, M., Goormastic, M., Settle, M., Schmitt, D., Fu, X., Thomson, L., Fox, P. L., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421109 · Cited by 737
Self-citationTardif, J.-C. (2007) · JAMA · doi:10.1001/jama.297.15.jpc70004 · Cited by 726
Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides
Rayner, K. J., Esau, C. C., Hussain, F. N., McDaniel, A. L., Marshall, S. M., van Gils, J. M., Ray, T. D., Sheedy, F. J., Goedeke, L., Liu, X., et al. (2011) · Nature · doi:10.1038/nature10486 · Cited by 706 · cited 1×
“The therapeutic potential of miR-33 inhibitors to cause similar benefits in people was suggested by plasma levels of HDL-C and apoAI being raised in treated nonhuman primates.(56) Thus, antagonism of miR-33 may represent a novel approach to enhancing macrophage cholesterol efflux and raising HDL-C levels in the future.”
BackgroundSelf-citationRayner, K. J., Sheedy, F. J., Esau, C. C., Hussain, F. N., Temel, R. E., Parathath, S., van Gils, J. M., Rayner, A. J., Chang, A. N., Suarez, Y., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57275 · Cited by 690 · cited 1×
“In LDLr mice treated with an inhibitor of miR-33, HDL-C levels rose concomitant with enrichment of M2 markers in plaque CD68+ cells.(55) The treated mice also exhibited plaque regression with fewer macrophages and macrophage-derived foam cells.”
BackgroundSelf-citationPresence of hypochlorite-modified proteins in human atherosclerotic lesions.
Hazell, L. J., Arnold, L., Flowers, D., Waeg, G., Malle, E., & Stocker, R. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118576 · Cited by 592
Plump, A. S., Scott, C. J., & Breslow, J. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.20.9607 · Cited by 568
Braun, A., Trigatti, B. L., Post, M. J., Sato, K., Simons, M., Edelberg, J. M., Rosenberg, R. D., Schrenzel, M., & Krieger, M. (2002) · Circulation Research · doi:10.1161/hh0302.104462 · Cited by 492
Bergt, C., Pennathur, S., Fu, X., Byun, J., O'Brien, K., McDonald, T. O., Singh, P., Anantharamaiah, G. M., Chait, A., Brunzell, J., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405292101 · Cited by 454
Zhang, Y., Zanotti, I., Reilly, M. P., Glick, J. M., Rothblat, G. H., & Rader, D. J. (2003) · Circulation · doi:10.1161/01.cir.0000086981.09834.e0 · Cited by 436
Davidson, W. S., Silva, R. A. G. D., Chantepie, S., Lagor, W. R., Chapman, M. J., & Kontush, A. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.186031 · Cited by 415
Sorrentino, S. A., Besler, C., Rohrer, L., Meyer, M., Heinrich, K., Bahlmann, F. H., Mueller, M., Horváth, T., Doerries, C., Heinemann, M., et al. (2010) · Circulation · doi:10.1161/circulationaha.108.836346 · Cited by 402
Inflammation Impairs Reverse Cholesterol Transport In Vivo
McGillicuddy, F. C., de la Llera Moya, M., Hinkle, C. C., Joshi, M. R., Chiquoine, E. H., Billheimer, J. T., Rothblat, G. H., & Reilly, M. P. (2009) · Circulation · doi:10.1161/circulationaha.108.810721 · Cited by 391
Chinetti-Gbaguidi, G., Baron, M., Bouhlel, M. A., Vanhoutte, J., Copin, C., Sebti, Y., Derudas, B., Mayi, T., Bories, G., Tailleux, A., et al. (2011) · Circulation Research · doi:10.1161/circresaha.110.233775 · Cited by 387
Shah, P. K., Yano, J., Reyes, O., Chyu, K.-Y., Kaul, S., Bisgaier, C. L., Drake, S., & Cercek, B. (2001) · Circulation · doi:10.1161/hc2501.092494 · Cited by 381
Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice.
Pászty, C., Maeda, N., Verstuyft, J., & Rubin, E. M. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117412 · Cited by 374
Regression of Atherosclerosis Induced by Liver-Directed Gene Transfer of Apolipoprotein A-I in Mice
Tangirala, R. K., Tsukamoto, K., Chun, S. H., Usher, D., Puré, E., & Rader, D. J. (1999) · Circulation · doi:10.1161/01.cir.100.17.1816 · Cited by 358
Navab, M., Hama, S. Y., Hough, G. P., Subbanagounder, G., Reddy, S. T., & Fogelman, A. M. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31582-0 · Cited by 334
Potteaux, S., Gautier, E. L., Hutchison, S. B., van Rooijen, N., Rader, D. J., Thomas, M. J., Sorci-Thomas, M. G., & Randolph, G. J. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43802 · Cited by 334
Feig, J. E., Rong, J. X., Shamir, R., Sanson, M., Vengrenyuk, Y., Liu, J., Rayner, K., Moore, K., Garabedian, M., & Fisher, E. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016086108 · Cited by 313
Self-citationGlycation impairs high-density lipoprotein function
Hedrick, C. C., Thorpe, S. R., Fu, M.-X., Harper, C. M., Yoo, J., Kim, S.-M., Wong, H., & Peters, A. L. (2000) · Diabetologia · doi:10.1007/s001250050049 · Cited by 310
Shaw, J. A., Bobik, A., Murphy, A., Kanellakis, P., Blombery, P., Mukhamedova, N., Woollard, K., Lyon, S., Sviridov, D., & Dart, A. M. (2008) · Circulation Research · doi:10.1161/circresaha.108.182063 · Cited by 275
Modification of High Density Lipoprotein by Myeloperoxidase Generates a Pro-inflammatory Particle
Undurti, A., Huang, Y., Lupica, J. A., Smith, J. D., DiDonato, J. A., & Hazen, S. L. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.047605 · Cited by 266
Self-citationPennathur, S., Bergt, C., Shao, B., Byun, J., Kassim, S. Y., Singh, P., Green, P. S., McDonald, T. O., Brunzell, J., Chait, A., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406762200 · Cited by 264
Prevalence of risk factors in men with premature coronary artery disease
Genest, J. J., McNamara, J. R., Salem, D. N., & Schaefer, E. J. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90924-a · Cited by 243
Gordon, S. M., Deng, J., Lu, L. J., & Davidson, W. S. (2010) · Journal of Proteome Research · doi:10.1021/pr100520x · Cited by 241
Prevalence of Risk Factors in Men With Premature Coronary Artery Disease
Genest, J. J., McNamara, J. R., Salem, D. N., & Schaefer, E. J. (1992) · Journal of Cardiopulmonary Rehabilitation · doi:10.1097/00008483-199203010-00011 · Cited by 217
Zheng, L., Settle, M., Brubaker, G., Schmitt, D., Hazen, S. L., Smith, J. D., & Kinter, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m407019200 · Cited by 207
Self-citationRemaley, A. T., Schumacher, U. K., Stonik, J. A., Farsi, B. D., Nazih, H., & Brewer, H. B. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.9.1813 · Cited by 204
Rong, J. X., Li, J., Reis, E. D., Choudhury, R. P., Dansky, H. M., Elmalem, V. I., Fallon, J. T., Breslow, J. L., & Fisher, E. A. (2001) · Circulation · doi:10.1161/hc4501.098952 · Cited by 204
Self-citationWu, Z., Wagner, M. A., Zheng, L., Parks, J. S., Shy, J. M., Smith, J. D., Gogonea, V., & Hazen, S. L. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1284 · Cited by 201
Self-citationRemaley, A. T., Thomas, F., Stonik, J. A., Demosky, S. J., Bark, S. E., Neufeld, E. B., Bocharov, A. V., Vishnyakova, T. G., Patterson, A. P., Eggerman, T. L., et al. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200475-jlr200 · Cited by 195
Metabolic and functional relevance of HDL subspecies
Asztalos, B. F., Tani, M., & Schaefer, E. J. (2011) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283468061 · Cited by 191
Miyazaki, A., Sakuma, S., Morikawa, W., Takiue, T., Miake, F., Terano, T., Sakai, M., Hakamata, H., Sakamoto, Y.-I., Naito, M., et al. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.11.1882 · Cited by 191
Methionine oxidation impairs reverse cholesterol transport by apolipoprotein A-I
Shao, B., Cavigiolio, G., Brot, N., Oda, M. N., & Heinecke, J. W. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802025105 · Cited by 189
Shao, B., Pennathur, S., & Heinecke, J. W. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.337345 · Cited by 170
Dysfunctional HDL as a Diagnostic and Therapeutic Target
Smith, J. D. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.179226 · Cited by 161
Self-citationFeig, J. E., Shang, Y., Rotllán, N., Vengrenyuk, Y., Wu, C., Shamir, R., Pineda‐Torra, I., Fernandez-Hernando, C. F., Fisher, E. A. A., & Garabedian, M. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028534 · Cited by 161
Self-citationSomatic Gene Transfer of Human ApoA-I Inhibits Atherosclerosis Progression in Mouse Models
Benoit, P., Emmanuel, F., Caillaud, J. M., Bassinet, L., Castro, G. R., Gallix, P., Fruchart, J., Branellec, D., Denèfle, P., & Duverger, N. (1999) · Circulation · doi:10.1161/01.cir.99.1.105 · Cited by 147
Suzuki, M., Pritchard, D. K., Becker, L., Hoofnagle, A. N., Tanimura, N., Bammler, T. K., Beyer, R. P., Bumgarner, R. E., Vaisar, T., de Beer, M. C., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.961193 · Cited by 145
Belalcazar, L. M., Merched, A. J., Carr, B. K., Oka, K., Chen, K., Pastore, L., Beaudet, A. L., & Chan, L. (2003) · Circulation · doi:10.1161/01.cir.0000066913.69844.b2 · Cited by 133
HDL cholesterol transport during inflammation
van der Westhuyzen, D. R., de Beer, F. C., & Webb, N. R. (2007) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328051b4fe · Cited by 129
Annema, W., Nijstad, N., Tölle, M., de Boer, J. F., Buijs, R. V. C., Heeringa, P., van der Giet, M., & Tietge, U. J. F. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m000323 · Cited by 127
Apolipoprotein A-I mimetic 4F alters the function of human monocyte-derived macrophages
Smythies, L. E., White, C. R., Maheshwari, A., Palgunachari, M. N., Anantharamaiah, G. M., Chaddha, M., Kurundkar, A., & Datta, G. (2010) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00467.2009 · Cited by 120
Regulation of reverse cholesterol transport - a comprehensive appraisal of available animal studies
Annema, W., & Tietge, U. J. F. (2012) · Nutrition & Metabolism · doi:10.1186/1743-7075-9-25 · Cited by 117
Gupta, H., Dai, L., Datta, G., Garber, D. W., Grenett, H. E., Li, Y., Mishra, V., Palgunachari, M. N., Handattu, S. P., Gianturco, S. H., et al. (2005) · Circulation Research · doi:10.1161/01.res.0000176530.66400.48 · Cited by 113
Valiyaveettil, M., Kar, N. S., Ashraf, M. Z., Byzova, T. V., Febbraio, M., & Podrez, E. A. (2007) · Blood · doi:10.1182/blood-2007-08-107813 · Cited by 108
Choudhury, R. P., Rong, J. X., Trogan, E., Elmalem, V. I., Dansky, H. M., Breslow, J. L., Witztum, J. L., Fallon, J. T., & Fisher, E. A. A. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000142808.34602.25 · Cited by 101
Self-citationPeng, D.-Q., Brubaker, G., Wu, Z., Zheng, L., Willard, B. B., Kinter, M. T., Hazen, S. L., & Smith, J. D. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.173815 · Cited by 99
Self-citationSingaraja, R. R., Eck, M. V., Bissada, N., Zimetti, F., Collins, H. L., Hildebrand, R. B., Hayden, A., Brunham, L. R., Kang, M. H., Fruchart, J., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.621433 · Cited by 85
In Vivo Reverse Cholesterol Transport From Macrophages Lacking ABCA1 Expression Is Impaired
Wang, M., Franklin, V., & Marcel, Y. L. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.146068 · Cited by 79
Peng, D.-Q., Wu, Z., Brubaker, G., Zheng, L., Settle, M., Gross, E. Z., Kinter, M. T., Hazen, S. L., & Smith, J. D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504092200 · Cited by 78
Self-citationTurner, S., Voogt, J. N., Davidson, M. H., Glass, A., Killion, S., Decaris, J., Mohammed, H., Minehira, K., Boban, D., Murphy, E. J., et al. (2012) · Journal of the American Heart Association · doi:10.1161/jaha.112.001826 · Cited by 74
Gene transfer of wild-type apoA-I and apoA-I Milano reduce atherosclerosis to a similar extent
Lebherz, C., Sanmiguel, J. C., Wilson, J. M., & Rader, D. J. (2007) · Cardiovascular Diabetology · doi:10.1186/1475-2840-6-15 · Cited by 72
HDL and Cardiovascular Risk: Time to Call the Plumber?
Hewing, B., Moore, K. J., & Fisher, E. A. A. (2012) · Circulation Research · doi:10.1161/circresaha.112.280958 · Cited by 67
Self-citationCraeyveld, E. V., Gordts, S. C., Nefyodova, E., Jacobs, F., & Geest, B. D. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0722-x · Cited by 67
Zymosan-mediated inflammation impairs in vivo reverse cholesterol transport
Malik, P., Berisha, S. Z., Santore, J., Agatisa-Boyle, C., Brubaker, G., & Smith, J. D. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m011122 · Cited by 62
Self-citationCuchel, M., Lund‐Katz, S., de la Llera-Moya, M., Millar, J. S., Chang, D. S., Fuki, I. V., Rothblat, G. H., Phillips, M. C., & Rader, D. J. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.196105 · Cited by 51
Calvo, C., Talussot, C., Ponsin, G., & Berthézène, F. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)81336-6 · Cited by 50
Malle, E., Wäg, G., Thiery, J., Sattler, W., & Gröne, H. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6074 · Cited by 28
Cited by
Pathophysiology of Atherosclerosis
Jebari-Benslaiman, S., Galicia-García, U., Larrea-Sebal, A., Olaetxea, J. R., Alloza, I., Vandenbroeck, K., Benito-Vicente, A., & Martín, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063346 · Cited by 1,010
Dysfunctional HDL and atherosclerotic cardiovascular disease
Rosenson, R. S., Brewer, H. B., Ansell, B. J., Barter, P., Chapman, M. J., Heinecke, J. W., Kontush, A., Tall, A. R., & Webb, N. R. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.124 · Cited by 822
Ouimet, M., Barrett, T. J., & Fisher, E. A. (2019) · Circulation Research · doi:10.1161/circresaha.119.312617 · Cited by 761
Self-citationThe Gut Microbial Endocrine Organ: Bacterially Derived Signals Driving Cardiometabolic Diseases
Brown, J. M., & Hazen, S. L. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-060513-093205 · Cited by 438
Self-citationAn abundant dysfunctional apolipoprotein A1 in human atheroma
Huang, Y., DiDonato, J. A., Levison, B. S., Schmitt, D., Li, L., Wu, Y., Buffa, J., Kim, T., Gerstenecker, G. S., Gu, X., et al. (2014) · Nature Medicine · doi:10.1038/nm.3459 · Cited by 364
Self-citation
Metadata
- Authors
- Fisher, E. A., Feig, J. E., Hewing, B., Hazen, S. L., & Smith, J. D.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 2012-12
- Volume
- 32
- Issue
- 12
- Pages
- 2813-2820
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2133990668
- Cited by
- 393
- References
- 75
- FWCI
- 32.77
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.